Regeneron Pharmaceuticals Inc REGN:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 7:00 AM EDT
982.00quote price arrow up+5.04 (+0.52%)
Volume
200
Close
976.96quote price arrow up+3.16 (+0.32%)
Volume
235,706
52 week range
684.80 - 998.33
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close976.96
  • 52 Week High998.33
  • 52 Week High Date02/28/24
  • 52 Week Low684.80
  • 52 Week Low Date06/28/23

Key Stats

  • Market Cap107.647B
  • Shares Out110.19M
  • 10 Day Average Volume0.49M
  • Dividend-
  • Dividend Yield-
  • Beta0.12
  • YTD % Change11.23

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close976.96
  • 52 Week High998.33
  • 52 Week High Date02/28/24
  • 52 Week Low684.80
  • 52 Week Low Date06/28/23
  • Market Cap107.647B
  • Shares Out110.19M
  • 10 Day Average Volume0.49M
  • Dividend-
  • Dividend Yield-
  • Beta0.12
  • YTD % Change11.23

RATIOS/PROFITABILITY

  • EPS (TTM)33.86
  • P/E (TTM)28.85
  • Fwd P/E (NTM)21.84
  • EBITDA (TTM)4.425B
  • ROE (TTM)15.28%
  • Revenue (TTM)13.10B
  • Gross Margin (TTM)86.32%
  • Net Margin (TTM)29.45%
  • Debt To Equity (MRQ)10.02%

EVENTS

  • Earnings Date08/01/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Profile

MORE
Regeneron Pharmaceuticals, Inc. is a fully integrated biotechnology company. The Company invents, develops, manufactures, and commercializes medicines for people with serious diseases. Its products and product candidates in development are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases, and rare diseases. The Company helps in...
Christopher Fenimore
Chief Financial Officer, Senior Vice President - Finance
Daniel Van Plew
Executive Vice President, General Manager - Industrial Operations and Product Supply
Marion McCourt
Executive Vice President - Commercial
Andrew Murphy Ph.D.
Executive Vice President - Research
Neil Stahl Ph.D.
Executive Vice President - Research and Development
Jason Pitofsky
Vice President, Controller
Address
777 Old Saw Mill River Road
Tarrytown, NY
10591
United States

Top Peers

SYMBOLLASTCHG%CHG
BIIB
Biogen Inc
225.34+3.84+1.73%
MRNA
Moderna Inc
125.67+8.36+7.13%
NVZMY
Novozymes A/S
60.45UNCHUNCH
ILMN
Illumina Inc
112.77+2.24+2.03%
BNTX
Biontech SE
92.72+1.05+1.15%